1,6,7-TrihydroxyxanthoneCAS# 25577-04-2 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 25577-04-2 | SDF | Download SDF |
PubChem ID | 71307364 | Appearance | Yellow powder |
Formula | C13H8O5 | M.Wt | 244.2 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1,6,7-trihydroxyxanthen-9-one | ||
SMILES | C1=CC2=C(C(=C1)O)C(=O)C3=CC(=C(C=C3O2)O)O | ||
Standard InChIKey | SIYGDHCRSSTGRT-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 1,6,7-Trihydroxyxanthone has anti-cancer activity ,at least in part, through the activation of miR-218 and suppression of Bmi-1 expression; can suppress cell growth and induce apoptosis in liver cancer cells. |
Targets | DNA/RNA Synthesis |
1,6,7-Trihydroxyxanthone Dilution Calculator
1,6,7-Trihydroxyxanthone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.095 mL | 20.475 mL | 40.95 mL | 81.9001 mL | 102.3751 mL |
5 mM | 0.819 mL | 4.095 mL | 8.19 mL | 16.38 mL | 20.475 mL |
10 mM | 0.4095 mL | 2.0475 mL | 4.095 mL | 8.19 mL | 10.2375 mL |
50 mM | 0.0819 mL | 0.4095 mL | 0.819 mL | 1.638 mL | 2.0475 mL |
100 mM | 0.041 mL | 0.2048 mL | 0.4095 mL | 0.819 mL | 1.0238 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Efetaal
Catalog No.:BCN8494
CAS No.:2556-10-7
- 7-Methoxy-4-methylcoumarin
Catalog No.:BCN6540
CAS No.:2555-28-4
- 1-(4-Hydroxybenzoyl)glucose
Catalog No.:BCN6900
CAS No.:25545-07-7
- Propidium iodide
Catalog No.:BCC8015
CAS No.:25535-16-4
- Mayumbine
Catalog No.:BCN5123
CAS No.:25532-45-0
- Z-Ile-Glu-Pro-Phe-Ome
Catalog No.:BCC5526
CAS No.:255257-97-4
- Isoferulic acid
Catalog No.:BCN5122
CAS No.:25522-33-2
- Ibotenic acid
Catalog No.:BCC6591
CAS No.:2552-55-8
- Bruceine A
Catalog No.:BCC5311
CAS No.:25514-31-2
- Bruceine C
Catalog No.:BCN8000
CAS No.:25514-30-1
- Bruceine B
Catalog No.:BCN7615
CAS No.:25514-29-8
- 1-Acetyl-4-piperidinecarboxylic acid
Catalog No.:BCC8447
CAS No.:25503-90-6
- Delta-Tocotrienol
Catalog No.:BCN6696
CAS No.:25612-59-3
- 7beta-Acetoxytaxuspine C
Catalog No.:BCN7219
CAS No.:256347-91-8
- BAY 41-2272
Catalog No.:BCC7932
CAS No.:256376-24-6
- SEW 2871
Catalog No.:BCC7312
CAS No.:256414-75-2
- Schleicheol 1
Catalog No.:BCN4661
CAS No.:256445-66-6
- Schleicheol 2
Catalog No.:BCN5125
CAS No.:256445-68-8
- Ac2-12
Catalog No.:BCC5826
CAS No.:256447-08-2
- Preisocalamendiol
Catalog No.:BCN5126
CAS No.:25645-19-6
- Dactylorhin A
Catalog No.:BCN8217
CAS No.:256459-34-4
- Nantenine
Catalog No.:BCN7788
CAS No.:2565-01-7
- Aponorhyoscine
Catalog No.:BCN1871
CAS No.:25650-56-0
- Cannabigerol
Catalog No.:BCN5127
CAS No.:25654-31-3
MiR-218-targeting-Bmi-1 mediates the suppressive effect of 1,6,7-trihydroxyxanthone on liver cancer cells.[Pubmed:25416134]
Apoptosis. 2015 Jan;20(1):75-82.
Traditional Chinese medicine is recently emerged as anti-cancer therapy or adjuvant with reduced side-effects and improved quality of life. In the present study, an active ingredient, 1,6,7-Trihydroxyxanthone (THA), derived from Goodyera oblongifolia was found to strongly suppress cell growth and induce apoptosis in liver cancer cells. MicroRNAs are a group of small non-coding RNAs that regulate gene expression at post-transcriptional levels. Our results demonstrated that miR-218 was up-regulated and oncogene Bmi-1 was down-regulated by THA treatment. Further investigation showed that THA-induced-miR-218 up-regulation could lead to activation of tumor suppressor P16(Ink4a) and P14(ARF), the main down-stream targets of Bmi-1. In conclusion, THA might be a potential anti-cancer drug candidate, at least in part, through the activation of miR-218 and suppression of Bmi-1 expression.